D04.62

Clinical Causes: Excessive exposure to ultraviolet (UV) radiation from sunlight or tanning beds. Repeated skin injuries or chronic skin inflammation. Immune system suppression, either from medications or medical conditions. Prolonged exposure to certain chemicals or irritants. Genetic predisposition affecting skin cell growth and repair.

Key Symptoms: Presence of ashy, scaly patches or spots on the skin. Lesions that may be raised or flat with irregular borders. Areas that may bleed, ooze, or become crusted over. Lesions that persist despite over-the-counter treatments. Usually asymptomatic but may cause itchiness or tenderness.

Diagnosis Path: Diagnosis begins with a thorough physical examination, focusing on the skin lesion in question. A biopsy is essential, where a small sample of the affected skin is removed and examined under a microscope to confirm the presence of carcinoma in situ. Additional imaging studies might be conducted if invasion or spread is suspected, though CIS typically remains localized. Dermatologists may also perform other diagnostic procedures like dermoscopy to evaluate skin patterns and structures more closely.

Treatment Protocols: Effective management of carcinoma in situ of the skin generally involves local treatments aimed at removing or destroying the abnormal cells. Common options include: - **Surgical excision:** Cutting out the lesion with some surrounding healthy tissue. - **Cryotherapy:** Freezing the lesion with liquid nitrogen to destroy abnormal cells. - **Topical medications:** Application of creams containing medications such as imiquimod or fluorouracil to promote immune response and destroy abnormal cells. - **Photodynamic therapy:** Using light-activated drugs to target cancer cells. - **Curettage and electrodessication:** Scraping away the lesion and destroying residual cells using electric current. Follow-up is crucial to monitor for recurrence or progression, and lifestyle modifications, including sun protection, are recommended to help prevent future skin issues.